Filing Details
- Accession Number:
- 0001209191-14-028937
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2014-04-23 19:19:23
- Reporting Period:
- 2014-04-23
- Filing Date:
- 2014-04-23
- Accepted Time:
- 2014-04-23 19:19:23
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1280776 | Vital Therapies Inc | VTL | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1307958 | M Philip Croxford | C/O Vital Therapies, Inc. 15010 Avenue Of Science, Suite 200 San Diego CA 92128 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2014-04-23 | 1,500 | $12.00 | 17,841 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2014-04-23 | 7,250 | $0.00 | 25,091 | No | 4 | C | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct | |
No | 4 | C | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Senior Convertible Preferred Stock | Disposition | 2014-04-23 | 7,250 | $0.00 | 7,250 | $0.00 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
0 | No | 4 | C | Direct |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Common Stock | 16,341 | Direct |
Footnotes
- Each share of Senior Convertible Preferred Stock automatically converted into the Registrant's common stock on a one-for-one basis immediately prior to the closing of the Registrant's initial public offering and had no expiration date.